Home・Список акций・Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals Inc

Открыт

СекторЗдравоохранение

4.36 1.4

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

4.26

Макс.

4.44

Ключевые показатели
By Trading Economics
Доход	11M 51M
Продажи	6.5M 113M
P/E Средняя по отрасли	5.45 57.371
Прибыль на акцию	0.31
Рентабельность продаж	45.374
Сотрудники	100
EBITDA	6.2M 81M

Дивиденды
By Acuity
Следующий отчет о доходах	9 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-7.1M 720M
Предыдущая цена открытия	2.96
Предыдущая цена закрытия	4.36

Новостные настроения

By Acuity

50%

156 / 340 Рейтинг в Healthcare

Ironwood Pharmaceuticals Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

18 авг. 2026 г., 19:36 UTC

Ironwood Pharmaceuticals Inc shares are lower today amid cautious market sentiment influenced by rising treasury yields and inflation concerns.

17 авг. 2026 г., 19:36 UTC

Ironwood Pharmaceuticals Inc is trading higher, maintaining its position near the upper end of its one-month range amid rising Treasury yields and inflation concerns.

14 авг. 2026 г., 23:01 UTC

Ironwood Pharmaceuticals shares declined in after-market trading, following a drop in U.S. retail sales that raised concerns about consumer spending and economic health.

13 авг. 2026 г., 23:36 UTC

Ironwood Pharmaceuticals Inc shares are lower during after-market hours, with no specific news identified to explain the decline. Trading activity remains routine.

12 авг. 2026 г., 19:21 UTC

Ironwood Pharmaceuticals is higher Wednesday, buoyed by overall strength in U.S. stocks, despite a recent pullback earlier in the session.

11 авг. 2026 г., 22:06 UTC

Ironwood Pharmaceuticals Inc shares are higher in after-market trading, with no specific news identified to explain the movement. The stock remains above its 20-day moving average.

10 авг. 2026 г., 19:36 UTC

Ironwood Pharmaceuticals Inc shares are lower today, with no specific news identified. The stock remains significantly down since Friday's close amid broader market volatility.

7 авг. 2026 г., 19:46 UTC

Ironwood Pharmaceuticals Inc shares are higher during Friday's session, maintaining a position above the 20-day moving average, despite earlier fluctuations.

6 авг. 2026 г., 23:06 UTC

Ironwood Pharmaceuticals shares are higher in after-market hours, reflecting positive movement since Thursday's close. No specific news was identified to explain the price action.

5 авг. 2026 г., 23:02 UTC

Ironwood Pharmaceuticals shares are higher in after-market trading, continuing a notable increase since Wednesday's close, despite no specific news identified.

4 авг. 2026 г., 23:01 UTC

Ironwood Pharmaceuticals Inc. shares are lower in after-market trading, showing routine volatility while remaining above the 20-day moving average. No specific news was identified.

3 авг. 2026 г., 19:26 UTC

Ironwood Pharmaceuticals is trading higher today, continuing a rally since Friday's close, amid broader market gains and falling energy prices.

31 июл. 2026 г., 23:26 UTC

Ironwood Pharmaceuticals Inc shares are trading higher in after-market hours, maintaining upward momentum since Friday's close. No specific news was identified for this movement.

30 июл. 2026 г., 20:51 UTC

Ironwood Pharmaceuticals shares declined in after-market trading, despite broader market gains. The stock remains below its 20-day moving average and near a one-month low.

29 июл. 2026 г., 20:04 UTC

Ironwood Pharmaceuticals Inc shares are trading lower amid broader market dynamics, including rising oil prices due to escalating Middle East tensions.

27 июл. 2026 г., 20:06 UTC

Ironwood Pharmaceuticals shares are higher today, reflecting broader market dynamics, despite earlier declines and a significant drop in oil prices.

24 июл. 2026 г., 23:26 UTC

Ironwood Pharmaceuticals shares gained modestly in after-market trading, following a volatile session amid broader turmoil in the bond market.

20 июл. 2026 г., 18:36 UTC

Ironwood Pharmaceuticals Inc is trading higher, reaching a session peak before settling within its one-month range. No specific news was identified for today's movement.

Сравнение c конкурентами

Изменение цены

Ironwood Pharmaceuticals Inc Прогноз

Консенсус по рейтингу

By TipRanks

Покупка

1 ratings

Покупка

Удержание

Продажа

Основано на мнении 1 аналитиков, присваивавших рейтинги акциям Ironwood Pharmaceuticals Inc – Данные за последние 3 месяца.

Настроения

By Acuity

156 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, Saudi Arabia, and China, as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; Apraglutide, a next-generation, long-acting synthetic peptide analog of glucagon-like peptide-2, as a differentiated therapeutic for rare diseases, including short bowel syndrome dependent on parenteral support and acute graft versus host disease; and CNP-104, an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.